Researchers find new genes that contribute to hypoplastic left heart syndrome

Sanofi and Re­gen­eron’s Dupix­ent has notched an­oth­er in­di­ca­tion in the EU, this time for a com­mon lung dis­ease, mark­ing the first-ever tar­get­ed ther­a­py for the

The FDA approved Pfizer’s Abrysvo based on the findings from the Phase III MATISSE clinical trial. Credit: Pfizer. The US Food and Drug Administration (FDA)